Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Cyclacel Pharmaceuticals, Inc."
Count: 19
Selected: 0
NCT IDTitle
NCT01303796A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
NCT05358379A Study to Investigate CYC140, in Subjects With Advanced Solid Tumors and Lymphoma
NCT04017546CYC065 CDK Inhibitor and Venetoclax Study in Relapsed/Refractory AML or MDS
NCT03884829A Phase I Study of CYC140, a PLK-1 Inhibitor, in Advanced Leukemias or MDS
NCT03739554CYC065 CDK Inhibitor and Venetoclax Study in Relapsed/Refractory CLL
NCT02552953A Pharmacologic Study of CYC065, a Cyclin Dependent Kinase Inhibitor, in Patients With Advanced Cancers
NCT05168904A Study to Investigate Fadraciclib (CYC065), in Subjects With Leukemia or Myelodysplastic Syndrome (MDS)
NCT04983810A Study to Investigate Fadraciclib (CYC065), in Subjects With Advanced Solid Tumors and Lymphoma
NCT00590187Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients
NCT00999401A Study of Oral Sapacitabine and Oral Seliciclib in Patients With Advanced Solid Tumors
NCT00885963A Study of Oral Sapacitabine in Patients With Previously Treated Non-Small Cell Lung Cancer
NCT00560716A Phase I Pharmacologic Study of CYC116, an Oral Aurora Kinase Inhibitor, in Patients With Advanced Solid Tumors
NCT00476554A Randomized Phase II Study of Oral Sapacitabine in Patients With Advanced Cutaneous T-cell Lymphoma
NCT00372073Efficacy Study of Oral Seliciclib to Treat Non-Small Cell Lung Cancer
NCT00380653Safety and Pharmacology Study of Sapacitabine to Treat Advanced Leukemias or Myelodysplastic Syndromes
NCT01211457Study of Sapacitabine in Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS)
NCT01253460Sapacitabine, Cyclophosphamide, Rituximab for Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma (CLL/SLL) With Deletion (11q22-23)
NCT03641755Olaparib + Sapacitabine in BRCA Mutant Breast Cancer
NCT02649751Evaluation of (R)-Roscovitine Safety and Effects in Subjects With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation